Key Insights

Highlights

Success Rate

56% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

23.5%

4 terminated out of 17 trials

Success Rate

55.6%

-31.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results56% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (6)
P 1 (6)
P 2 (4)

Trial Status

Completed5
Terminated4
Recruiting4
Active Not Recruiting3
Not Yet Recruiting1

Trial Success Rate

55.6%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT06343402Phase 1Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NCT04702009Phase 2CompletedPrimary

Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer

NCT05969860Phase 2Recruiting

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT04924192Phase 2TerminatedPrimary

A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer

NCT06917079Phase 1Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT04785287Phase 1TerminatedPrimary

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

NCT04819997Not ApplicableActive Not RecruitingPrimary

A Nurse-Led Intervention for Fear of Progression in Advanced Cancer

NCT05705492Phase 2Recruiting

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

NCT05256290Phase 1Active Not Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT03707938Phase 1Active Not RecruitingPrimary

Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

NCT05640765Not ApplicableCompletedPrimary

BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced Lung Cancers

NCT05891197Terminated

A Biomarker Screening Protocol for Participants With Solid Tumors

NCT05274451Phase 1Terminated

A Study to Investigate LYL797 in Adults With Solid Tumors

NCT03776253Not ApplicableCompletedPrimary

Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer

NCT06374160Not ApplicableNot Yet RecruitingPrimary

Exercise in Patients With Advanced Non-small Cell Lung Cancer

NCT04229381Not ApplicableCompletedPrimary

Resiliency Among Older Adults Receiving Lung Cancer Treatment

NCT05342571Not ApplicableCompletedPrimary

A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer

Showing all 17 trials

Research Network

Activity Timeline